Recently [7], we provided evidence that expression of a designer chimeric RNA targeting JAZF1 and SUZ12 genes in human endometrial stromal cells also drives the formation of JAZF1-SUZ12, a cancer fusion gene commonly found in low-grade endometrial stromal sarcomas patients [8,9,10]. The gene discussed is JAZF1; the disease is cancer.